Protonix Injection, Powder, For Solution
Product Images NDC 55154-4236

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 55154-4236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0e813403 54ba 4523 9123 592cd3232ade 00

The packaging label for Protonix I.V. injection, powder for solution, 40 mg strength by Cardinal Health 107, LLC. The label indicates 5 single-dose vials of 40 mg pantoprazole sodium (equivalent to 45.1 mg pantoprazole sodium) for intravenous use. It provides storage instructions, warnings, and distributor information including Wyeth Pharmaceuticals and Cardinal Health.*

FDA Label Image

Chemical Structure (Protonix Iv 01)

Chemical structure of pantoprazole sodium, as indicated in the image. The diagram shows the molecular arrangement of the active ingredient pantoprazole sodium.*

FDA Label Image

Protonix Iv 02

This packaging label belongs to Pfizer Injectables, indicating distribution by Wyeth Pharmaceuticals LLC, a Pfizer Inc subsidiary located in Philadelphia, PA. It is related to injectable pharmaceutical products. No specific drug name or strength information is visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.